Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enteric pathogen" refers to any microorganism—bacterial, viral, or parasitic—that is capable of causing disease in the gastrointestinal tract, most commonly through oral-fecal transmission, and is associated with symptoms such as diarrhea, malabsorption, and intestinal inflammation[1][5][3]. Common bacterial enteric pathogens include Salmonella, pathogenic Escherichia coli (E. coli), Shigella, Campylobacter, and Vibrio species[2][3][7][10]. Some enteric pathogens act via invasion of the intestinal epithelial barrier, secretion of toxins, or triggering of inflammation, and are a major cause of global foodborne diseases and childhood morbidity[1][9]. In summary, "Enteric pathogen" is not a canonical drug target or specific molecular entity but a general term for microbes that infect the GI tract. For structured information, a more precise target (such as specific bacterial toxins, virulence factors, or microbial receptors) should be specified instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enteric pathogen.